此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Horizontal vs Vertical Scleral Tunnels in Flanged IOL Fixation (HORVER)

2026年7月7日 更新者:Sebahattin Celik MD、Yuzuncu Yil University

Horizontal Versus Vertical Scleral Tunnel Orientation in Flanged Intrascleral Fixation: A 2-Year Comparative Study

This study compares the 2-year outcomes of horizontal versus vertical scleral tunnel orientation in flanged intrascleral intraocular lens (IOL) fixation surgery. The primary outcome is the proportion of eyes achieving refraction within ±0.50 diopters of the target at 2 years. Secondary outcomes include IOL tilt measured by anterior segment optical coherence tomography (AS-OCT), iris capture, conjunctival erosion, and other complications. The study aims to determine whether tunnel orientation is associated with differing outcomes in this surgical technique.

研究概览

详细说明

Background: The management of aphakia, crystalline lens luxation, and intraocular lens (IOL) luxation in the absence of adequate capsular support remains challenging. Traditional surgical options include anterior chamber IOLs, iris-fixated IOLs, and scleral-sutured posterior chamber IOLs, each carrying significant long-term risks. In 2017, Yamane and colleagues introduced a sutureless flanged intrascleral IOL fixation technique that rapidly gained worldwide acceptance. A critical yet under-investigated surgical variable is the orientation of the scleral tunnels relative to the limbus. Some surgeons create tunnels parallel to the limbus (horizontal/tangential), others perpendicular (vertical/radial), based on personal preference rather than high-level evidence.

Objective: To evaluate whether horizontal versus vertical scleral tunnel orientation is associated with differing 2-year outcomes in flanged intrascleral IOL fixation.

Study Design: This is a retrospective observational cohort study conducted at a single tertiary referral centre.

Participants: A total of 107 eyes (43 vertical tunnels, 64 horizontal tunnels) with complete 24-month follow-up are included. Surgeries are performed by two experienced vitreoretinal surgeons.

Interventions: All procedures follow the original Yamane flanged intrascleral fixation method with intentional variation in tunnel orientation only. The horizontal tunnel group receives tunnels parallel to the limbus (tangential), while the vertical tunnel group receives tunnels perpendicular to the limbus (radial). A three-piece foldable acrylic IOL (Alcon AcrySof MA60AC) is used in all eyes.

Outcome Measures: The primary outcome is the proportion of eyes achieving mean absolute error (MAE) within ±0.50D of target refraction at 2 years. Secondary outcomes include MAE at 2 years, IOL tilt measured using anterior segment optical coherence tomography (AS-OCT), iris capture, conjunctival erosion, cystoid macular oedema, epiretinal membrane, retinal detachment, vitreous haemorrhage, hypotony, corneal oedema, early IOP elevation, best-corrected visual acuity (BCVA), and vector astigmatism analysis using the Alpins method.

Statistical Analysis: Propensity score matching (1:1) will be performed to address selection bias. Multivariate logistic regression and a multilevel mixed-effects model with surgeon as random effect will be used to adjust for confounders including surgical period, age, and baseline refraction. For the primary outcome, a single pre-specified comparison will be made with a two-tailed significance level of α = 0.05. For secondary outcomes, the False Discovery Rate (FDR) using the Benjamini-Hochberg procedure (q = 0.05) will be applied to control for Type I error inflation.

Timeline: Data were collected from patients who underwent surgery between March 1, 2022, and March 1, 2025. Minimum follow-up is 24 months, with final data collection completed in March 2025.

研究类型

观察性的

注册 (实际的)

107

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

取样方法

非概率样本

研究人群

Patients with aphakia, crystalline lens luxation, or intraocular lens luxation in the absence of adequate capsular support who underwent flanged intrascleral IOL fixation surgery at a single tertiary referral centre between March 1, 2022, and March 1, 2025. All patients were aged 18 years or older and completed 24 months of follow-up.

描述

Inclusion Criteria:

  • Age ≥ 18 years
  • Complicated aphakia defined as absence of adequate capsular support following cataract extraction, lens trauma, or previous lensectomy
  • Crystalline lens luxation defined as partial or complete displacement of the natural lens due to zonular weakness
  • Intraocular lens (IOL) luxation defined as partial or complete dislocation of a previously implanted IOL
  • Inadequate capsular support (<180° of intact zonular or capsular support)
  • Ability to complete scheduled follow-up visits
  • Complete follow-up data available

Exclusion Criteria:

  • Previous scleral buckling surgery within 6 months
  • Pars plana vitrectomy within 3 months
  • Active uveitis
  • Active endophthalmitis
  • Uncontrolled scleritis or scleral thinning
  • Corneal decompensation (endothelial cell density <1000 cells/mm²)
  • Uncontrolled glaucoma (IOP >25 mmHg despite maximum therapy)
  • History of penetrating keratoplasty, DALK, DSEK, or DMEK
  • History of corneal refractive surgery
  • Active proliferative diabetic retinopathy
  • Pregnancy or breastfeeding
  • Inability to complete 24-month follow-up

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Vertical Scleral Tunnel Group
Patients who underwent flanged intrascleral IOL fixation with scleral tunnels created perpendicular to the limbus (radial/vertical orientation).
Sutureless flanged intrascleral fixation of a three-piece foldable acrylic IOL (Alcon AcrySof MA60AC). Two partial-thickness scleral tunnels are created 2.0 mm posterior to the limbus, 180° apart. Haptics are externalized through the tunnels, and a flange is created on each haptic tip using thermal cautery. Tunnel orientation varied intentionally: horizontal (parallel to limbus) or vertical (perpendicular to limbus).
Horizontal Scleral Tunnel Group
Patients who underwent flanged intrascleral IOL fixation with scleral tunnels created parallel to the limbus (tangential/horizontal orientation).
Sutureless flanged intrascleral fixation of a three-piece foldable acrylic IOL (Alcon AcrySof MA60AC). Two partial-thickness scleral tunnels are created 2.0 mm posterior to the limbus, 180° apart. Haptics are externalized through the tunnels, and a flange is created on each haptic tip using thermal cautery. Tunnel orientation varied intentionally: horizontal (parallel to limbus) or vertical (perpendicular to limbus).

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Proportion of Eyes Achieving Mean Absolute Error (MAE) Within ±0.50 Diopters of Target Refraction
大体时间:24 Months
The proportion of eyes achieving mean absolute error (MAE) within ±0.50 diopters of the target spherical equivalent refraction at 24 months postoperatively.
24 Months

次要结果测量

结果测量
措施说明
大体时间
Mean Absolute Error (MAE) at 2 Years
大体时间:24 Months
Mean absolute error in spherical equivalent refraction at 24 months postoperatively.
24 Months
IOL Tilt Angle
大体时间:24 Months
Intraocular lens tilt angle measured using anterior segment optical coherence tomography (AS-OCT) at 24 months postoperatively.
24 Months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2022年3月1日

初级完成 (实际的)

2025年3月1日

研究完成 (实际的)

2025年3月1日

研究注册日期

首次提交

2026年7月1日

首先提交符合 QC 标准的

2026年7月7日

首次发布 (实际的)

2026年7月14日

研究记录更新

最后更新发布 (实际的)

2026年7月14日

上次提交的符合 QC 标准的更新

2026年7月7日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

其他研究编号

  • GOKAEK-2024-04-02 (其他标识符:Van Training and Research Hospital Ethics Committee)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Individual participant data will not be shared due to institutional data protection policies and patient privacy regulations. Anonymized aggregate data may be available from the corresponding author upon reasonable request.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅